Congress has been closely investigating the problem of skyrocketing prescription drug costs and pricing practices. As a result, pharmaceutical drug manufacturers are ramping up their lobbying efforts this year. Pharmaceutical Research and Manufacturers of America (PhRMA) represents 37 of the countries’ biopharmaceutical research companies and has...

Prescription drug prices continue to rise and have become one the most important healthcare issues facing the nation. In an effort to address the problem, President Trump announced his drug pricing plan on May 11. After his remarks, analysts are concerned that it could significantly...